Condition
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
JWK001 subretinal therapy for neovascular AMD
This study tests a single subretinal dose of JWK001 at different levels in people with wet age-related macular degeneration who have previously responded to anti-VEGF treatment.
-
Ixo-vec Contralateral Dosing in Bilateral Wet AMD
Researchers are testing whether giving Ixo-vec to the second eye of adults with bilateral wet AMD is safe and helps vision over time.
Quick answers
How many Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.